306 related articles for article (PubMed ID: 7370375)
21. Power and sample size simulations for Randomized Play-the-Winner rules.
Guimaraes P; Palesch Y
Contemp Clin Trials; 2007 Jul; 28(4):487-99. PubMed ID: 17321219
[TBL] [Abstract][Full Text] [Related]
22. Application of restricted sequential design in a clinical protocol.
Thompson EI
Cancer Treat Rep; 1980; 64(2-3):399-403. PubMed ID: 7407776
[TBL] [Abstract][Full Text] [Related]
23. [Use of prognostic knowledge in the planning and analysis of randomized therapeutic trials].
Byar D; Chastang C
Bull Cancer; 1987; 74(2):177-84. PubMed ID: 3607300
[TBL] [Abstract][Full Text] [Related]
24. Dynamic treatment allocation adjusting for prognostic factors for more than two treatments.
Dror S; Faraggi D; Reiser B
Biometrics; 1995 Dec; 51(4):1338-43. PubMed ID: 8589225
[TBL] [Abstract][Full Text] [Related]
25. A new procedure for group sequential analysis in clinical trials.
Falissard B; Lellouch J
Biometrics; 1992 Jun; 48(2):373-88. PubMed ID: 1637967
[TBL] [Abstract][Full Text] [Related]
26. Bayesian adaptive biased-coin designs for clinical trials with normal responses.
Atkinson AC; Biswas A
Biometrics; 2005 Mar; 61(1):118-25. PubMed ID: 15737084
[TBL] [Abstract][Full Text] [Related]
27. On the generalization of surgical trial results.
van der Linden W
Acta Chir Scand; 1980; 146(4):229-34. PubMed ID: 7468047
[TBL] [Abstract][Full Text] [Related]
28. A two-stage procedure for bioequivalence studies.
Racine-Poon A; Grieve AP; Flühler H; Smith AF
Biometrics; 1987 Dec; 43(4):847-56. PubMed ID: 3427169
[TBL] [Abstract][Full Text] [Related]
29. Analysis of two-period crossover design in a multicenter clinical trial.
Castellana JV; Patel HI
Biometrics; 1985 Dec; 41(4):969-77. PubMed ID: 3830261
[TBL] [Abstract][Full Text] [Related]
30. Group sequential t-test for clinical trials with small sample sizes across stages.
Shao J; Feng H
Contemp Clin Trials; 2007 Sep; 28(5):563-71. PubMed ID: 17434814
[TBL] [Abstract][Full Text] [Related]
31. Designs for experiments--parallel comparisons of treatment.
Lavori PW; Louis TA; Bailar JC; Polansky M
N Engl J Med; 1983 Nov; 309(21):1291-9. PubMed ID: 6633587
[TBL] [Abstract][Full Text] [Related]
32. Statistical inference and the design of clinical trials.
Berry DA
Biomedicine; 1980 Feb; 32(1):4-7. PubMed ID: 7370380
[TBL] [Abstract][Full Text] [Related]
33. [Group allocation by random procedure in field trial (Latin square in working out the list for random allocation) (author's transl)].
Bencić Z
Lijec Vjesn; 1981 Oct; 103(10):425-30. PubMed ID: 7341896
[No Abstract] [Full Text] [Related]
34. Design and analysis of group sequential logrank tests in maximum duration versus information trials.
Kim K; Boucher H; Tsiatis AA
Biometrics; 1995 Sep; 51(3):988-1000. PubMed ID: 7548714
[TBL] [Abstract][Full Text] [Related]
35. Three-period crossover designs for two treatments.
Ebbutt AF
Biometrics; 1984 Mar; 40(1):219-24. PubMed ID: 6733230
[TBL] [Abstract][Full Text] [Related]
36. On design considerations and randomization-based inference for community intervention trials.
Gail MH; Mark SD; Carroll RJ; Green SB; Pee D
Stat Med; 1996 Jun; 15(11):1069-92. PubMed ID: 8804140
[TBL] [Abstract][Full Text] [Related]
37. Comparison of stratification and adaptive methods for treatment allocation in an acute stroke clinical trial.
Weir CJ; Lees KR
Stat Med; 2003 Mar; 22(5):705-26. PubMed ID: 12587101
[TBL] [Abstract][Full Text] [Related]
38. Further results on a multiple-testing procedure for clinical trials.
Seigel D; Milton RC
Biometrics; 1983 Dec; 39(4):921-8. PubMed ID: 6671127
[TBL] [Abstract][Full Text] [Related]
39. A two stage conditional power adaptive design adjusting for treatment by covariate interaction.
Ayanlowo AO; Redden DT
Contemp Clin Trials; 2008 May; 29(3):428-38. PubMed ID: 18053774
[TBL] [Abstract][Full Text] [Related]
40. On constrained balance randomization for clinical trials.
Titterington DM
Biometrics; 1983 Dec; 39(4):1083-6. PubMed ID: 6671120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
